Vanda Pharmaceuticals Income Statement (2009-2026) | VNDA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	67.90M	70.09M	68.02M	60.19M	64.39M	65.32M	64.48M	62.50M	46.06M	38.81M	45.27M	47.46M	50.47M	47.65M	53.19M	50.04M	52.59M	56.26M	57.22M	51.72M
Cost of Revenue (Quarter)	6.57M	6.80M	6.24M	5.67M	6.06M	6.32M	6.24M	4.77M	3.50M	3.06M	3.46M	3.44M	2.73M	2.55M	2.59M	3.52M	2.74M	2.95M	3.83M	3.16M
Gross Profit (Quarter)	61.33M	63.30M	61.78M	54.53M	58.33M	59.00M	58.24M	57.72M	42.56M	35.75M	41.81M	44.02M	47.74M	45.10M	50.59M	46.52M	49.85M	53.30M	53.38M	48.56M
Operating items
Amortization - Intangibles (Quarter)	0.37M	0.37M	0.37M	0.40M	0.40M	0.38M	0.42M	0.38M	0.40M	0.40M	0.95M	2.02M	1.80M	1.80M	1.75M	1.75M	1.80M	1.80M	1.71M	1.99M
Depreciation & Amortization - Total (Quarter)	0.34M	0.34M	0.37M	0.32M	0.31M	0.30M	0.27M	0.29M	0.22M	0.20M	0.20M	0.21M	0.22M	0.22M	0.26M	0.23M	0.27M	0.30M	0.30M	0.27M
Research & Development (Quarter)	20.25M	19.65M	19.33M	20.97M	21.49M	24.86M	18.45M	19.24M	16.65M	16.60M	24.34M	21.15M	16.66M	16.78M	19.84M	35.71M	21.99M	22.56M	-65.86M	28.43M
Selling, General & Administrative (Quarter)	28.35M	32.46M	33.45M	40.85M	33.00M	29.85M	32.78M	36.10M	28.40M	24.77M	23.61M	30.09M	39.47M	37.57M	39.28M	50.08M	64.62M	60.27M	62.98M	68.36M
Other Operating Expenses (Quarter)	6.59M	6.83M	6.23M	5.72M	6.13M	6.40M	6.35M	4.86M	3.65M	3.24M	4.21M	5.25M	4.27M	4.09M	4.08M	5.04M	4.22M	4.41M	100.15M	4.87M
Operating Expenses (Quarter)	55.53M	59.28M	59.38M	67.86M	60.93M	61.41M	57.85M	60.49M	48.92M	44.81M	52.37M	56.70M	60.62M	58.65M	63.46M	91.07M	91.09M	87.54M	97.57M	101.94M
Operating Income (Quarter)	12.37M	10.82M	8.64M	-7.67M	3.46M	3.91M	6.63M	2.00M	-2.87M	-6.00M	-7.09M	-9.23M	-10.15M	-11.00M	-10.28M	-41.03M	-38.50M	-31.28M	-40.35M	-50.22M
EBIT (Quarter)	12.37M	10.82M	8.64M	-7.67M	3.46M	3.91M	6.63M	2.00M	-2.87M	-6.00M	-7.09M	-9.23M	-10.15M	-11.00M	-10.28M	-41.03M	-38.50M	-31.28M	-40.35M	-50.22M
Non-operating items
Interest & Investment Income (Quarter)
Net income details
EBT (Quarter)	12.60M	10.72M	8.61M	-7.56M	3.79M	5.46M	9.61M	5.53M	2.59M	-0.12M	-1.66M	-4.66M	-5.52M	-6.24M	-6.50M	-37.37M	-34.89M	-28.39M	-38.00M	-48.42M
Tax Provisions (Quarter)	2.95M	2.95M	1.53M	-1.13M	1.20M	2.20M	2.75M	2.30M	1.10M	-0.26M	0.73M	-0.50M	-1.00M	-0.90M	-1.62M	-7.87M	-7.70M	-5.80M	103.23M	0.10M
Profit After Tax (Quarter)	9.65M	7.77M	7.08M	-6.43M	2.57M	3.27M	6.86M	3.25M	1.52M	0.14M	-2.40M	-4.15M	-4.52M	-5.32M	-4.91M	-29.49M	-27.21M	-22.59M	-141.19M	-48.57M
Income from Continuing Operations (Quarter)	9.65M	7.77M	7.08M	-6.43M	2.59M	3.26M	6.86M	3.23M	1.49M	0.14M	-2.39M	-4.16M	-4.52M	-5.34M	-4.88M	-29.49M	-27.19M	-22.59M	-141.23M	-48.52M
Consolidated Net Income (Quarter)	9.65M	7.77M	7.08M	-6.43M	2.59M	3.26M	6.86M	3.23M	1.49M	0.14M	-2.39M	-4.16M	-4.52M	-5.34M	-4.88M	-29.49M	-27.19M	-22.59M	-141.23M	-48.52M
Income towards Parent Company (Quarter)	9.65M	7.77M	7.08M	-6.43M	2.59M	3.26M	6.86M	3.23M	1.49M	0.14M	-2.39M	-4.16M	-4.52M	-5.34M	-4.88M	-29.49M	-27.19M	-22.59M	-141.23M	-48.52M
Net Income towards Common Stockholders (Quarter)	9.65M	7.77M	7.08M	-6.43M	2.59M	3.26M	6.86M	3.23M	1.49M	0.14M	-2.39M	-4.16M	-4.52M	-5.34M	-4.88M	-29.49M	-27.19M	-22.59M	-141.23M	-48.52M
Additional items
EPS (Basic) (Quarter)	0.17	0.14	0.13	-0.11	0.05	0.06	0.12	0.06	0.03	0.00	-0.05	-0.07	-0.08	-0.09	-0.09	-0.50	-0.46	-0.38	-2.39	-0.82
EPS (Weighted Average and Diluted) (Quarter)	0.17	0.14	0.12	-0.11	0.05	0.06	0.12	0.06	0.03	0.00	-0.05	-0.07	-0.08	-0.09	-0.09	-0.50	-0.46	-0.38	-2.39	-0.82
Shares Outstanding (Weighted Average) (Quarter)	55.37M	55.47M	55.55M	56.11M	56.31M	56.57M	56.46M	57.01M	57.45M	57.33M	57.38M	57.76M	58.22M	58.10M	58.15M	58.53M	58.99M	59.09M	58.93M	59.46M
Shares Outstanding (Diluted Average) (Quarter)	56.90M	57.04M	56.92M	56.11M	56.31M	56.97M	56.98M	57.40M	57.54M	57.51M	57.56M	57.76M	58.22M	58.26M	58.15M	58.53M	58.76M	58.87M	58.93M	59.46M
EBITDA (Quarter)	12.71M	11.16M	9.01M	-7.35M	3.77M	4.21M	6.90M	2.29M	-2.64M	-5.79M	-6.89M	-9.03M	-9.93M	-10.78M	-10.02M	-40.80M	-38.24M	-30.98M	-40.05M	-49.95M
Tax Rate (Quarter)	23.41%	27.52%	17.79%	14.99%	31.66%	40.29%	28.63%	41.61%	42.44%	214.17%	-43.95%	10.72%	18.09%	14.41%	24.95%	21.07%	22.07%	20.43%	-271.64%	-0.21%

Research Tools

Developers

Vanda Pharmaceuticals Income Statement (2009-2026) | VNDA

Research Tools

Developers

Vanda Pharmaceuticals Income Statement (2009-2026) | VNDA

Create an account

Sign In

Reset Password